Lisa C. Holthof

Preclinical Activity of JNJ-7957, a Novel BCMA×CD3 Bispecific Antibody for the Treatment of Multiple Myeloma, Is Potentiated by Daratumumab

Kristine A. Frerichs, Marloes E.C. Broekmans, Jhon A. Marin Soto et al. · Clinical Cancer Research · 2020 · 87 citations · Full text

Medicine, Immunology, Pharmacology +17

STAT3 inhibition specifically in human monocytes and macrophages by CD163-targeted corosolic acid-containing liposomes

Morten Nørgaard Andersen, Anders Etzerodt, Jonas Heilskov Graversen et al. · Cancer Immunology Immunotherapy · 2019 · 58 citations · Full text

Life Sciences, Cell Biology, Immunology +14

Bone Marrow Mesenchymal Stromal Cells Can Render Multiple Myeloma Cells Resistant to Cytotoxic Machinery of CAR T Cells through Inhibition of Apoptosis

Lisa C. Holthof, Jort J. van der Schans, Afroditi Katsarou et al. · Clinical Cancer Research · 2021 · 56 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Bone Marrow Mesenchymal Stromal Cell-mediated Resistance in Multiple Myeloma Against NK Cells can be Overcome by Introduction of CD38-CAR or TRAIL-variant

Lisa C. Holthof, Arwen Stikvoort, Hilma J. van der Horst et al. · HemaSphere · 2021 · 23 citations · Full text

Medicine, Immunology, Oncology +16

The Impact and Modulation of Microenvironment-Induced Immune Resistance Against CAR T Cell and Antibody Treatments in Multiple Myeloma

Lisa C. Holthof, Hilma J. van der Horst, Renée Poels et al. · Blood · 2019 · 15 citations

Medicine, Immunology, Oncology +14